My CommentsI do not generally keep reviewing a penny stock with questionable management, but some shareholders of this biotech have asked. The sign things were gone side ways was when your Directors granted themselves an enormous compensation package with no achievments . I continue to not recommend this Company till i see a new President and Chairman and a board overhaul. All i have ever seen from this Company is an orchestrated price manipulation, followed by financings that distort your value. We will defer from recommending this stock.